Overview

Pharmacokinetics and Safety of Solithromycin in Adolescents and Children

Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
Pediatric study to evaluate the safety and pharmacokinetics of solithromycin (oral and intravenous) in children ages 0 to 17
Phase:
Phase 1
Details
Lead Sponsor:
Cempra Inc
Melinta Therapeutics, Inc.
Collaborator:
Department of Health and Human Services
Treatments:
Solithromycin